I take the silence as a positive. NKP are busy with BFS finalising "N" deal and negotiating a JV. Plenty of company making announcements in the pipeline.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling